The use of amniotic membrane transplantation for ocular surface reconstruction: a review and series of 58 equine clinical cases (2002–2008)

Authors

Errata

This article is corrected by:

  1. Errata: Corrigendum Volume 14, Issue 2, 142, Article first published online: 1 March 2011

Address communications to:
Dr. C. E. Plummer
Tel.: 352 392 4700
Fax: 352 392 6125
e-mail: plummerc@mail.vetmed.ufl.edu

Abstract

Amniotic membrane transplantation (AMT) is an effective clinical therapy for reconstruction of the ocular surface in human and veterinary patients. Amnion is avascular and strong, contains antiangiogenic and antiinflammatory properties and growth factors, and has properties that prevent or decrease fibrosis in healing tissue. Indications for its use are steadily growing and include grafting to replace diseased, missing or excised tissue, patching to support diseased tissue during the healing process and as a substrate for the expansion of epithelial cells for transplantation to the cornea. AMT through a combination of mechanical and biologic factors can preserve the integrity of the globe, optimize the visual outcome, and minimize scarring in severely diseased corneas.

Ancillary